by Anna Sauerbier
- Outbreak of Zika Virus Disease – general information
- The Zika virus and potential neurological effects
- The European Medicines Agency (EMA) has released a revised guideline on medicines for the treatment of Alzheimer’s disease and other types of dementias for a six-month public consultation.
- Anavex announces positive dose-response data for ANAVEX 2-73 in Alzheimer’s disease patients
- Researchers have shown that graphene can be used to make electrodes that can be implanted in the brain, which could potentially be used to restore sensory functions for amputee or paralysed patients, or for individuals with motor disorders such as Parkinson’s disease.
- The European Commission is launching a public consultation on the review of the European Disability Strategy
- NHS England will invest an additional £1 billion a year into improving mental health services.
